During the past decade, Churchill Hospital; Department of Oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Churchill Hospital; Department of Oncology" are "Breast Cancer" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Colorectal Cancer" (1 trials) and "Unresectable Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "Churchill Hospital; Department of Oncology" in a lesser frequency.

Most popular intervention types in "Churchill Hospital; Department of Oncology" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an Engineered Anti-PDL1 Antibody" (1 trials), "Cobimetinib" (1 trials), "Fulvestrant" (1 trials) and "Inavolisib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Churchill Hospital; Department of Oncology" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Churchill Hospital; Department of Oncology". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Churchill Hospital; Department of Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Churchill Hospital; Department of Oncology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".